Company Blog Venture-backed Celularity receives FDA approval for early trials of a new cell therapy for COVID-19 Celularity, the venture-backed developer of novel cell therapies for cancer treatments, has received an initial clearance from the Food and Drug Administration to begin early-stage clinical trials on a potential...
Venture-backed Celularity receives FDA approval for early trials of a new cell therapy for COVID-19